Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Galectin-3 Inhibitor Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Natural
1.2.3 Synthetic
1.3 Market by Application
1.3.1 Global Galectin-3 Inhibitor Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diabetes
1.3.3 Heart Failure
1.3.4 Asthma
1.3.5 Rheumatoid Arthritis
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Galectin-3 Inhibitor Market Perspective (2018-2033)
2.2 Galectin-3 Inhibitor Growth Trends by Region
2.2.1 Global Galectin-3 Inhibitor Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Galectin-3 Inhibitor Historic Market Size by Region (2018-2023)
2.2.3 Galectin-3 Inhibitor Forecasted Market Size by Region (2024-2033)
2.3 Galectin-3 Inhibitor Market Dynamics
2.3.1 Galectin-3 Inhibitor Industry Trends
2.3.2 Galectin-3 Inhibitor Market Drivers
2.3.3 Galectin-3 Inhibitor Market Challenges
2.3.4 Galectin-3 Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Galectin-3 Inhibitor Players by Revenue
3.1.1 Global Top Galectin-3 Inhibitor Players by Revenue (2018-2023)
3.1.2 Global Galectin-3 Inhibitor Revenue Market Share by Players (2018-2023)
3.2 Global Galectin-3 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Galectin-3 Inhibitor Revenue
3.4 Global Galectin-3 Inhibitor Market Concentration Ratio
3.4.1 Global Galectin-3 Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Galectin-3 Inhibitor Revenue in 2022
3.5 Galectin-3 Inhibitor Key Players Head office and Area Served
3.6 Key Players Galectin-3 Inhibitor Product Solution and Service
3.7 Date of Enter into Galectin-3 Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Galectin-3 Inhibitor Breakdown Data by Type
4.1 Global Galectin-3 Inhibitor Historic Market Size by Type (2018-2023)
4.2 Global Galectin-3 Inhibitor Forecasted Market Size by Type (2024-2033)
5 Galectin-3 Inhibitor Breakdown Data by Application
5.1 Global Galectin-3 Inhibitor Historic Market Size by Application (2018-2023)
5.2 Global Galectin-3 Inhibitor Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Galectin-3 Inhibitor Market Size (2018-2033)
6.2 North America Galectin-3 Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Galectin-3 Inhibitor Market Size by Country (2018-2023)
6.4 North America Galectin-3 Inhibitor Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Galectin-3 Inhibitor Market Size (2018-2033)
7.2 Europe Galectin-3 Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Galectin-3 Inhibitor Market Size by Country (2018-2023)
7.4 Europe Galectin-3 Inhibitor Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Galectin-3 Inhibitor Market Size (2018-2033)
8.2 Asia-Pacific Galectin-3 Inhibitor Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Galectin-3 Inhibitor Market Size by Region (2018-2023)
8.4 Asia-Pacific Galectin-3 Inhibitor Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Galectin-3 Inhibitor Market Size (2018-2033)
9.2 Latin America Galectin-3 Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Galectin-3 Inhibitor Market Size by Country (2018-2023)
9.4 Latin America Galectin-3 Inhibitor Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Galectin-3 Inhibitor Market Size (2018-2033)
10.2 Middle East & Africa Galectin-3 Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Galectin-3 Inhibitor Market Size by Country (2018-2023)
10.4 Middle East & Africa Galectin-3 Inhibitor Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlycoMimetics (US)
11.1.1 GlycoMimetics (US) Company Detail
11.1.2 GlycoMimetics (US) Business Overview
11.1.3 GlycoMimetics (US) Galectin-3 Inhibitor Introduction
11.1.4 GlycoMimetics (US) Revenue in Galectin-3 Inhibitor Business (2018-2023)
11.1.5 GlycoMimetics (US) Recent Development
11.2 Galectin Therapeutics Inc (US)
11.2.1 Galectin Therapeutics Inc (US) Company Detail
11.2.2 Galectin Therapeutics Inc (US) Business Overview
11.2.3 Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Introduction
11.2.4 Galectin Therapeutics Inc (US) Revenue in Galectin-3 Inhibitor Business (2018-2023)
11.2.5 Galectin Therapeutics Inc (US) Recent Development
11.3 G3 Pharmaceuticals (India)
11.3.1 G3 Pharmaceuticals (India) Company Detail
11.3.2 G3 Pharmaceuticals (India) Business Overview
11.3.3 G3 Pharmaceuticals (India) Galectin-3 Inhibitor Introduction
11.3.4 G3 Pharmaceuticals (India) Revenue in Galectin-3 Inhibitor Business (2018-2023)
11.3.5 G3 Pharmaceuticals (India) Recent Development
11.4 iTeos (US)
11.4.1 iTeos (US) Company Detail
11.4.2 iTeos (US) Business Overview
11.4.3 iTeos (US) Galectin-3 Inhibitor Introduction
11.4.4 iTeos (US) Revenue in Galectin-3 Inhibitor Business (2018-2023)
11.4.5 iTeos (US) Recent Development
11.5 MandalMed, Inc (US)
11.5.1 MandalMed, Inc (US) Company Detail
11.5.2 MandalMed, Inc (US) Business Overview
11.5.3 MandalMed, Inc (US) Galectin-3 Inhibitor Introduction
11.5.4 MandalMed, Inc (US) Revenue in Galectin-3 Inhibitor Business (2018-2023)
11.5.5 MandalMed, Inc (US) Recent Development
11.6 Angion (US)
11.6.1 Angion (US) Company Detail
11.6.2 Angion (US) Business Overview
11.6.3 Angion (US) Galectin-3 Inhibitor Introduction
11.6.4 Angion (US) Revenue in Galectin-3 Inhibitor Business (2018-2023)
11.6.5 Angion (US) Recent Development
11.7 Novartis AG (Switzerland)
11.7.1 Novartis AG (Switzerland) Company Detail
11.7.2 Novartis AG (Switzerland) Business Overview
11.7.3 Novartis AG (Switzerland) Galectin-3 Inhibitor Introduction
11.7.4 Novartis AG (Switzerland) Revenue in Galectin-3 Inhibitor Business (2018-2023)
11.7.5 Novartis AG (Switzerland) Recent Development
11.8 Galecto Biotech (Denmark)
11.8.1 Galecto Biotech (Denmark) Company Detail
11.8.2 Galecto Biotech (Denmark) Business Overview
11.8.3 Galecto Biotech (Denmark) Galectin-3 Inhibitor Introduction
11.8.4 Galecto Biotech (Denmark) Revenue in Galectin-3 Inhibitor Business (2018-2023)
11.8.5 Galecto Biotech (Denmark) Recent Development
11.9 Pfizer Inc. (US)
11.9.1 Pfizer Inc. (US) Company Detail
11.9.2 Pfizer Inc. (US) Business Overview
11.9.3 Pfizer Inc. (US) Galectin-3 Inhibitor Introduction
11.9.4 Pfizer Inc. (US) Revenue in Galectin-3 Inhibitor Business (2018-2023)
11.9.5 Pfizer Inc. (US) Recent Development
11.10 Lilly (US)
11.10.1 Lilly (US) Company Detail
11.10.2 Lilly (US) Business Overview
11.10.3 Lilly (US) Galectin-3 Inhibitor Introduction
11.10.4 Lilly (US) Revenue in Galectin-3 Inhibitor Business (2018-2023)
11.10.5 Lilly (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Galectin-3 Inhibitor Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Natural
Table 3. Key Players of Synthetic
Table 4. Global Galectin-3 Inhibitor Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Galectin-3 Inhibitor Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Galectin-3 Inhibitor Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Galectin-3 Inhibitor Market Share by Region (2018-2023)
Table 8. Global Galectin-3 Inhibitor Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Galectin-3 Inhibitor Market Share by Region (2024-2033)
Table 10. Galectin-3 Inhibitor Market Trends
Table 11. Galectin-3 Inhibitor Market Drivers
Table 12. Galectin-3 Inhibitor Market Challenges
Table 13. Galectin-3 Inhibitor Market Restraints
Table 14. Global Galectin-3 Inhibitor Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Galectin-3 Inhibitor Market Share by Players (2018-2023)
Table 16. Global Top Galectin-3 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Galectin-3 Inhibitor as of 2022)
Table 17. Ranking of Global Top Galectin-3 Inhibitor Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Galectin-3 Inhibitor Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Galectin-3 Inhibitor Product Solution and Service
Table 21. Date of Enter into Galectin-3 Inhibitor Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Galectin-3 Inhibitor Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Galectin-3 Inhibitor Revenue Market Share by Type (2018-2023)
Table 25. Global Galectin-3 Inhibitor Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Galectin-3 Inhibitor Revenue Market Share by Type (2024-2033)
Table 27. Global Galectin-3 Inhibitor Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Galectin-3 Inhibitor Revenue Market Share by Application (2018-2023)
Table 29. Global Galectin-3 Inhibitor Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Galectin-3 Inhibitor Revenue Market Share by Application (2024-2033)
Table 31. North America Galectin-3 Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Galectin-3 Inhibitor Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Galectin-3 Inhibitor Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Galectin-3 Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Galectin-3 Inhibitor Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Galectin-3 Inhibitor Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Galectin-3 Inhibitor Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Galectin-3 Inhibitor Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Galectin-3 Inhibitor Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Galectin-3 Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Galectin-3 Inhibitor Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Galectin-3 Inhibitor Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Galectin-3 Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Galectin-3 Inhibitor Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Galectin-3 Inhibitor Market Size by Country (2024-2033) & (US$ Million)
Table 46. GlycoMimetics (US) Company Detail
Table 47. GlycoMimetics (US) Business Overview
Table 48. GlycoMimetics (US) Galectin-3 Inhibitor Product
Table 49. GlycoMimetics (US) Revenue in Galectin-3 Inhibitor Business (2018-2023) & (US$ Million)
Table 50. GlycoMimetics (US) Recent Development
Table 51. Galectin Therapeutics Inc (US) Company Detail
Table 52. Galectin Therapeutics Inc (US) Business Overview
Table 53. Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Product
Table 54. Galectin Therapeutics Inc (US) Revenue in Galectin-3 Inhibitor Business (2018-2023) & (US$ Million)
Table 55. Galectin Therapeutics Inc (US) Recent Development
Table 56. G3 Pharmaceuticals (India) Company Detail
Table 57. G3 Pharmaceuticals (India) Business Overview
Table 58. G3 Pharmaceuticals (India) Galectin-3 Inhibitor Product
Table 59. G3 Pharmaceuticals (India) Revenue in Galectin-3 Inhibitor Business (2018-2023) & (US$ Million)
Table 60. G3 Pharmaceuticals (India) Recent Development
Table 61. iTeos (US) Company Detail
Table 62. iTeos (US) Business Overview
Table 63. iTeos (US) Galectin-3 Inhibitor Product
Table 64. iTeos (US) Revenue in Galectin-3 Inhibitor Business (2018-2023) & (US$ Million)
Table 65. iTeos (US) Recent Development
Table 66. MandalMed, Inc (US) Company Detail
Table 67. MandalMed, Inc (US) Business Overview
Table 68. MandalMed, Inc (US) Galectin-3 Inhibitor Product
Table 69. MandalMed, Inc (US) Revenue in Galectin-3 Inhibitor Business (2018-2023) & (US$ Million)
Table 70. MandalMed, Inc (US) Recent Development
Table 71. Angion (US) Company Detail
Table 72. Angion (US) Business Overview
Table 73. Angion (US) Galectin-3 Inhibitor Product
Table 74. Angion (US) Revenue in Galectin-3 Inhibitor Business (2018-2023) & (US$ Million)
Table 75. Angion (US) Recent Development
Table 76. Novartis AG (Switzerland) Company Detail
Table 77. Novartis AG (Switzerland) Business Overview
Table 78. Novartis AG (Switzerland) Galectin-3 Inhibitor Product
Table 79. Novartis AG (Switzerland) Revenue in Galectin-3 Inhibitor Business (2018-2023) & (US$ Million)
Table 80. Novartis AG (Switzerland) Recent Development
Table 81. Galecto Biotech (Denmark) Company Detail
Table 82. Galecto Biotech (Denmark) Business Overview
Table 83. Galecto Biotech (Denmark) Galectin-3 Inhibitor Product
Table 84. Galecto Biotech (Denmark) Revenue in Galectin-3 Inhibitor Business (2018-2023) & (US$ Million)
Table 85. Galecto Biotech (Denmark) Recent Development
Table 86. Pfizer Inc. (US) Company Detail
Table 87. Pfizer Inc. (US) Business Overview
Table 88. Pfizer Inc. (US) Galectin-3 Inhibitor Product
Table 89. Pfizer Inc. (US) Revenue in Galectin-3 Inhibitor Business (2018-2023) & (US$ Million)
Table 90. Pfizer Inc. (US) Recent Development
Table 91. Lilly (US) Company Detail
Table 92. Lilly (US) Business Overview
Table 93. Lilly (US) Galectin-3 Inhibitor Product
Table 94. Lilly (US) Revenue in Galectin-3 Inhibitor Business (2018-2023) & (US$ Million)
Table 95. Lilly (US) Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Galectin-3 Inhibitor Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Galectin-3 Inhibitor Market Share by Type: 2022 VS 2033
Figure 3. Natural Features
Figure 4. Synthetic Features
Figure 5. Global Galectin-3 Inhibitor Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Galectin-3 Inhibitor Market Share by Application: 2022 VS 2033
Figure 7. Diabetes Case Studies
Figure 8. Heart Failure Case Studies
Figure 9. Asthma Case Studies
Figure 10. Rheumatoid Arthritis Case Studies
Figure 11. Other Case Studies
Figure 12. Galectin-3 Inhibitor Report Years Considered
Figure 13. Global Galectin-3 Inhibitor Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Galectin-3 Inhibitor Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Galectin-3 Inhibitor Market Share by Region: 2022 VS 2033
Figure 16. Global Galectin-3 Inhibitor Market Share by Players in 2022
Figure 17. Global Top Galectin-3 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Galectin-3 Inhibitor as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Galectin-3 Inhibitor Revenue in 2022
Figure 19. North America Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Galectin-3 Inhibitor Market Share by Country (2018-2033)
Figure 21. United States Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Galectin-3 Inhibitor Market Share by Country (2018-2033)
Figure 25. Germany Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Galectin-3 Inhibitor Market Share by Region (2018-2033)
Figure 33. China Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Galectin-3 Inhibitor Market Share by Country (2018-2033)
Figure 41. Mexico Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Galectin-3 Inhibitor Market Share by Country (2018-2033)
Figure 45. Turkey Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Galectin-3 Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. GlycoMimetics (US) Revenue Growth Rate in Galectin-3 Inhibitor Business (2018-2023)
Figure 48. Galectin Therapeutics Inc (US) Revenue Growth Rate in Galectin-3 Inhibitor Business (2018-2023)
Figure 49. G3 Pharmaceuticals (India) Revenue Growth Rate in Galectin-3 Inhibitor Business (2018-2023)
Figure 50. iTeos (US) Revenue Growth Rate in Galectin-3 Inhibitor Business (2018-2023)
Figure 51. MandalMed, Inc (US) Revenue Growth Rate in Galectin-3 Inhibitor Business (2018-2023)
Figure 52. Angion (US) Revenue Growth Rate in Galectin-3 Inhibitor Business (2018-2023)
Figure 53. Novartis AG (Switzerland) Revenue Growth Rate in Galectin-3 Inhibitor Business (2018-2023)
Figure 54. Galecto Biotech (Denmark) Revenue Growth Rate in Galectin-3 Inhibitor Business (2018-2023)
Figure 55. Pfizer Inc. (US) Revenue Growth Rate in Galectin-3 Inhibitor Business (2018-2023)
Figure 56. Lilly (US) Revenue Growth Rate in Galectin-3 Inhibitor Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed